Unlock this StockReport nowClick to Unlock

Inno-Gene SA

IGN PLN1.17 0.0  3.5%
15/01/19

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 TTM 2018E 2019E CAGR / Avg
Revenue PLNm
Operating Profit PLNm
Net Profit PLNm
EPS Reported PLN
EPS Normalised PLN
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps PLN
Capex ps PLN
Free Cashflow ps PLN
Dividends
Dividend ps PLN
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc PLNm
Working Capital PLNm
Net Fixed Assets PLNm
Net Debt PLNm
Book Value PLNm
Average Shares m
Book Value ps PLN +5.2%

FINANCIAL BRIEF: For the nine months ended 30 September 2018, Inno-Gene SA revenues decreased 11% to PLN2.4M. Net income applicable to common stockholders decreased 1% to PLN713K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Other Operating Income decrease of 100% to PLN2K (income), Subsidies decrease of 42% to PLN366K (income). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
C+
C+
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Sep '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2018
31st Dec 2019

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (PLN) (PLN) (PLN) (PLN) (PLN) (PLN)
Consensus Estimate
1m Change
3m Change
1 brokers Broker Consensus Trend
Broker Recommendations for Inno-Gene SA
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
East Value Research ,

Profile Summary

Inno-Gene SA is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.

Directors: Krzysztof Krolikowski (CSU) , Jacek Wojciechowicz (CMG) , Andrzej Mackiewicz (VSU) , Kamil Malek (SEC) , Jakub Sitarz (SUB) , Rafal Sobczak (SUB) , Piotr Staniszewski (SUB) ,

No. of Employees: 27 No. of Shareholders: n/a


Last Annual December 31st, 2017
Last Interim September 30th, 2018
Incorporated June 10, 2010
Public Since February 8, 2011
Shares in Issue 5,701,081
Free Float 5.70m (100.0%)
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Warsaw Stock Exchange
Eligible for an ISA? a SIPP?

IGN Share Price Performance IGNQuote
PLN1.17
0.0  3.5%
Traded 4:35pm · Minimum 15 min delayed · NMS:

Latest IGN News Announcements (delayed)

Upcoming IGN Events
Friday 28th June, 2019 (estimate)
Inno-Gene SA Annual Shareholders Meeting

Recent ↓
Saturday 30th June, 2018
Inno-Gene SA Annual Shareholders Meeting
Friday 30th June, 2017
Inno-Gene SA Annual Shareholders Meeting
Tuesday 30th May, 2017
Inno-Gene SA Annual Shareholders Meeting
Friday 23rd September, 2016
Inno-Gene SA Extraordinary Shareholders Meeting


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.


Should you buy IGN

Access IGN Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis